Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
An Implantable Spinal Cord Stimulation Pain Management System
This study has been completed.
Sponsored by: Boston Scientific Corporation
Information provided by: Boston Scientific Corporation
ClinicalTrials.gov Identifier: NCT00205855
  Purpose

There are many treatment options available for the management of chronic pain . Some include, but are not limited to, over-the-counter medications, Non-Steroidal Anti-Inflammatory Drugs, Physical Therapy, Transcutaneous Electrical Nerve Stimulation (TENS) and nerve blocks. Historically, the mainstay of pain treatment has been pharmacotherapy. However, pharmacotherapy has varying degrees of effectiveness and is often associated with undesirable side effects. Although many patients are successfully treated, for those who fail some of these more conservative therapies the remaining option is limited to spinal cord stimulation (SCS), proven to be an effective therapy to more than half of those failing conservative treatments . Over 50% of those who have failed these more conservative methods of pain management, can now, under the guidance of a clinician utilizing SCS, have their pain levels successfully managed. SCS is a less invasive therapy that is a reversible treatment with greater long-term benefits than more permanent, radical approaches and one that deserves greater consideration in the management of chronic, intractable pain.


Condition Intervention Phase
Chronic Pain
Pain, Intractable
Pain
Back Pain
Failed Back Surgery Syndrome
Device: Stimulus
Device: Precision
Phase III

MedlinePlus related topics: Back Pain
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
Official Title: Stimulus Confirmatory Study - An Implantable Spinal Cord Stimulation Pain Management System

Further study details as provided by Boston Scientific Corporation:

Primary Outcome Measures:
  • Demonstrate acceptable functionality and labeling in the use of the system

Secondary Outcome Measures:
  • Support future update to claims

Enrollment: 49
Study Start Date: February 2003
Study Completion Date: March 2005
Primary Completion Date: October 2003 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Diagnosed with chronic, intractable pain of the trunk and/or limbs which includes but is not limited to, unilateral or bilateral pain associated with any of the following: failed back surgery syndrome, intractable low back pain and leg pain.
  2. Be an appropriate candidate for surgery.
  3. Be capable of giving informed consent.
  4. Be capable and willing to follow all study related procedures.

Exclusion Criteria:

  1. Have an inability to operate the system either by self or care-giver.
  2. Are currently participating or have participated within the past 30 days in any clinical investigation that could conflict with the requirements of this study.
  3. Have any implanted electrical devices, regardless of whether active or inactive.
  4. Have any active implantable device regardless of whether stimulation is ON or OFF.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00205855

Locations
United States, Alabama
Alabama Pain Center
Huntsville, Alabama, United States, 35801
United States, California
California Pain Medicine Centers
Los Angeles, California, United States, 90059
Pacific Pain Treatment Center
San Francisco, California, United States, 94109
United States, Montana
Yellowstone Neurological Associates
Billings, Montana, United States, 59101
United States, New York
Northshore University Hospital
Syosset, New York, United States, 11791
United States, Ohio
Cleveland Clinic
Cleveland, Ohio, United States, 44195
United States, Texas
Dallas Neurological Associates
Dallas, Texas, United States, 75231
Texas Back Institute
Plano, Texas, United States, 75093
River Oaks Pain Management
Houston, Texas, United States, 77027
Sponsors and Collaborators
Boston Scientific Corporation
Investigators
Study Chair: Kay Adair Boston Scientific Corporation
  More Information

Responsible Party: Boston Scientific ( Pam Phongpharnich, Sr. Clinical Research Associate )
Study ID Numbers: CR-S-003
Study First Received: September 13, 2005
Last Updated: October 10, 2008
ClinicalTrials.gov Identifier: NCT00205855  
Health Authority: United States: Food and Drug Administration

Keywords provided by Boston Scientific Corporation:
Pain
Chronic Pain
Neurostimulation

Study placed in the following topic categories:
Pain, Intractable
Signs and Symptoms
Neurologic Manifestations
Pain
Back Pain

Additional relevant MeSH terms:
Pathologic Processes
Disease
Syndrome
Nervous System Diseases

ClinicalTrials.gov processed this record on January 16, 2009